Wellgistics Health Enters Material Agreement and Sells Unregistered Equity

Wellgistics Health, Inc. (WGRX) entered into a material definitive agreement and conducted unregistered sales of equity securities, according to an 8-K filed with the SEC on May 29, 2026.

The filing discloses Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. Per the SEC EDGAR record, the company with CIK 0002030763 and ticker WGRX is a non-watchlist public filer.

The material agreement changes the company's contractual position from its prior state with no such arrangement in force to one that now binds both Wellgistics Health and the named counterparty. The new contract, whose type and dollar size are detailed in the exhibits, takes effect immediately upon execution on or before the filing date of May 29, 2026.

The unregistered equity sales similarly shift the capitalization structure by issuing new shares or convertible securities to specific investors without SEC registration.

Downstream, the company must deliver the full text of the agreement as an exhibit in Item 9.01, making its terms public within the four-business-day window required for 8-K reports. The counterparty and any new shareholders now operate under the contract's performance milestones, which may require subsequent SEC filings such as a resale registration statement on Form S-1 or S-3 if the securities are to become tradable.

Regulation FD compliance also requires that any material nonpublic information disclosed in connection with the transaction not be shared selectively, triggering internal controls and potential Form 8-K amendments if additional details emerge.

This marks the latest capital markets and commercial transaction reported by Wellgistics Health since its most recent prior 8-K filings detailing operational developments in the pharmaceutical supply chain sector. The Form 8-K itself constitutes the primary public record and will be incorporated by reference into future registration statements and periodic reports.